Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society

References

• Hiramatsu K, Yamada T, Yukimura Y et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch. Intern. Med. 141(12), 1589–1593 (1981).
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Fardella C et al.; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(9), 3266–3281 (2008).
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed. Pharmacother. 54(Suppl. 1), 83s–85s (2000).
   Google Scholar
• Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 27(3), 193–202 (2004).
   PubMed Web of Science ®Google Scholar
• Naruse M, Tanaka T, Otani S, Ogawa J, Tanabe M, Ishizuka N; PHAS-J study group. [A study on the frequency of PHAS in hypertensive patients in Japan using the network of the National Hospital Organization (NHO).] Nippon Naibunpi Gakkai Zasshi 85, 246S (2009) (in Japanese).
   Google Scholar
• Komiya I, Yamada T, Takasu N et al. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin–aldosterone system. J. Hypertens. 15(1), 65–72 (1997).
   PubMed Web of Science ®Google Scholar
• [Guidelines for the Treatment of Hypertension 2009.] In: Committee for the Preparation of Guidelines for the Treatment of Hypertension, Japanese Society of Hypertension. Life Science Publishing, Tokyo (2009) (in Japanese).
   Google Scholar
• Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21(4), 315–318 (1994).
   PubMed Web of Science ®Google Scholar
• Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary hyperaldosteronism: a missed diagnosis in ‘essential hypertensives’? Aust. N. Z. J. Med. 26(4), 533–538 (1996).
   Google Scholar
• Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J. Hypertens. 19(3), 353–361 (2001).
   PubMed Web of Science ®Google Scholar
• Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85(8), 2854–2859 (2000).
   PubMed Web of Science ®Google Scholar
• Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45(8), 1243–1248 (2005).
   PubMed Web of Science ®Google Scholar
• Cicala MV, Mantero F. Primary aldosteronism: what consensus for the diagnosis. Best Pract. Res. Clin. Endocrinol. Metab. 24(6), 915–921 (2010).
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Omura M, Satoh F et al.; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism – the Japan Endocrine Society 2009. Endocr. J. 58(9), 711–721 (2011).
   PubMed Web of Science ®Google Scholar
• Fischer E, Beuschlein F, Bidlingmaier M, Reincke M. Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev. Endocr. Metab. Disord. 12(1), 43–48 (2011).
   Google Scholar
• Solar M, Malirova E, Ballon M, Pelouch R, Ceral J. Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients. Eur. J. Endocrinol. 166(4), 679–686 (2012).
   Google Scholar
• Nanba K, Tamanaha T, Nakao K et al. Confirmatory testing in primary aldosteronism. J. Clin. Endocrinol. Metab. 97(5), 1688–1694 (2012).
   Google Scholar
• Rossi GP, Seccia TM, Pessina AC. A diagnostic algorithm – the holy grail of primary aldosteronism. Nat. Rev. Endocrinol. 7(12), 697–699 (2011).
   Google Scholar
• Graham UM, Ellis PK, Hunter SJ, Leslie H, Mullan KR, Atkinson AB. 100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes. Clin. Endocrinol. (Oxf.) 76(1), 26–32 (2012).
   Google Scholar
• Patel SM, Lingam RK, Beaconsfield TI, Tran TL, Brown B. Role of radiology in the management of primary aldosteronism. Radiographics 27(4), 1145–1157 (2007).
   PubMed Web of Science ®Google Scholar
• Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens. Res. 29(11), 883–889 (2006).
   Google Scholar
• Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metab. Clin. Exp. 51(3), 350–355 (2002).
   PubMed Web of Science ®Google Scholar
• Sarlon-Bartoli G, Michel N, Taieb D et al. Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography. J. Hypertens. 29(6), 1196–1202 (2011).
   PubMed Web of Science ®Google Scholar
• Rossi GP, Barisa M, Allolio B et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J. Clin. Endocrinol. Metab. 97(5), 1606–1614 (2012).
   PubMed Web of Science ®Google Scholar
• Omura M, Nishikawa T. Adrenal venous sampling (AVS) is essential for detecting unilateral or bilateral adrenal lesions in primary aldosteronism. Endocr. J. 56(3), 533 (2009).
   Google Scholar
• Nishikawa T, Saito J, Omura M. Adrenal venous sampling is absolutely requisite for definitively diagnosing primary aldosteronism as well as for detecting laterality of the adrenal lesion. Hypertens. Res. 30(11), 1009–1010 (2007).
   Google Scholar
• Reardon MA, Angle JF, Abi-Jaoudeh N et al. Intraprocedural cortisol levels in the evaluation of proper catheter placement in adrenal venous sampling. J. Vasc. Interv. Radiol. 22(11), 1575–1580 (2011).
   Google Scholar
• Auchus RJ, Michaelis C, Wians FH Jr et al. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann. Surg. 249(2), 318–321 (2009).
   PubMed Web of Science ®Google Scholar
• Mengozzi G, Rossato D, Bertello C et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin. Chem. 53(11), 1968–1971 (2007).
   PubMed Web of Science ®Google Scholar
• Betz MJ, Degenhart C, Fischer E et al. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur. J. Endocrinol. 165(2), 301–306 (2011).
   PubMed Web of Science ®Google Scholar
• Seccia TM, Miotto D, De Toni R et al. Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism. J. Clin. Endocrinol. Metab. 96(5), E825–E829 (2011).
   Google Scholar
• Vonend O, Ockenfels N, Gao X et al.; German Conn’s Registry. Adrenal venous sampling: evaluation of the German Conn’s registry. Hypertension 57(5), 990–995 (2011).
   PubMed Web of Science ®Google Scholar
• Lau JH, Sze WC, Reznek RH et al. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clin. Endocrinol. (Oxf.) 76(2), 182–188 (2012).
   Google Scholar
• Omura M, Saito J, Matsuzawa Y, Nishikawa T. Supper-selective ACTH-stimulated adrenal vein sampling is necessary for detecting precisely functional state of various lesions in unilateral and bilateral adrenal disorders, inducing primary aldosteronism with subclinical Cushing’s syndrome. Endocr. J. 58(10), 919–920 (2011).
   Google Scholar
• Satoh F, Abe T, Tanemoto M et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens. Res. 30(11), 1083–1095 (2007).
   Google Scholar
• Mulatero P, Bertello C, Sukor N et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension 55(3), 667–673 (2010).
   Google Scholar
• Miotto D, De Toni R, Pitter G et al. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension 54(4), 885–889 (2009).
   Google Scholar
• Nishikawa T, Matsuzawa Y, Saito J, Omura M. Is it possible to extirpate cardiovascular events in primary aldosteronism after surgical treatment. Jap. Clin. Med. 1, 121–123 (2010).
   Google Scholar
• Auchus RJ, Wians FH Jr, Anderson ME et al. What we still do not know about adrenal vein sampling for primary aldosteronism. Horm. Metab. Res. 42(6), 411–415 (2010).
   Google Scholar
• Monticone S, Satoh F, Giacchetti G et al. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension 59(4), 840–846 (2012).
   Google Scholar
• Seccia TM, Miotto D, De Toni R et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 53(5), 761–766 (2009).
   PubMed Web of Science ®Google Scholar
• Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J. Hypertens. 26(5), 989–997 (2008).
   PubMed Web of Science ®Google Scholar
• Seccia TM, Miotto D, Battistel M et al. A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur. J. Endocrinol. 166(5), 869–875 (2012).
   Google Scholar
• Tanemoto M, Suzuki T, Abe M, Abe T, Ito S. Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling. Eur. J. Endocrinol. 160(3), 459–463 (2009).
   Google Scholar
• Mulatero P, di Cella SM, Monticone S et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J. Clin. Endocrinol. Metab. 97(3), 881–889 (2012).
   Google Scholar
• Young WF Jr, Stanson AW, Grant CS, Thompson GB, van Heerden JA. Primary aldosteronism: adrenal venous sampling. Surgery 120(6), 913–919; discussion 919 (1996).
   Google Scholar
• Nakamura Y, Satoh F, Morimoto R et al. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J. Clin. Endocrinol. Metab. 96(8), E1272–E1278 (2011).
   PubMedGoogle Scholar
• Auchus RJ, Chandler DW, Singeetham S et al. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism. J. Clin. Endocrinol. Metab. 92(7), 2648–2651 (2007).
   Google Scholar
• Kahn SL, Angle JF. Adrenal vein sampling. Tech. Vasc. Interv. Radiol. 13(2), 110–125 (2010).
   Google Scholar
• Rossi GP. Diagnosis and treatment of primary aldosteronism. Endocrinol. Metab. Clin. North Am. 40(2), 313–32, vii (2011).
   Google Scholar
• Young WF Jr. Endocrine hypertension: then and now. Endocr. Pract. 16(5), 888–902 (2010).
   Google Scholar
• Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr. J. 54(4), 487–495 (2007).
   PubMed Web of Science ®Google Scholar
• Weinberger MH, Grim CE, Hollifield JW et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann. Intern. Med. 90(3), 386–395 (1979).
   PubMed Web of Science ®Google Scholar
• Ganguly A. Primary aldosteronism. N. Engl. J. Med. 339(25), 1828–1834 (1998).
   PubMed Web of Science ®Google Scholar
• Stewart PM. Mineralocorticoid hypertension. Lancet 353(9161), 1341–1347 (1999).
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Biglieri EG, Ruiz AE. Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 58(5), 783–785 (1984).
   Web of Science ®Google Scholar
• Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J. Clin. Endocrinol. Metab. 94(7), 2437–2445 (2009).
   Google Scholar
• Fischer E, Beuschlein F, Degenhart C, Jung P, Bidlingmaier M, Reincke M. Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn’s Registry. Clin. Endocrinol. (Oxf.) 76(4), 473–477 (2012).
   Google Scholar
• Yoneda T, Demura M, Takata H et al. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. J. Clin. Endocrinol. Metab. 97(4), 1109–1113 (2012).
   PubMed Web of Science ®Google Scholar
• Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J. Clin. Endocrinol. Metab. 96(9), 2904–2911 (2011).
   PubMed Web of Science ®Google Scholar
• Lin YH, Lin LY, Chen A et al.; TAIPAI Study Group. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis 221(1), 154–159 (2012).
   Google Scholar
• Choi M, Scholl UI, Yue P et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331(6018), 768–772 (2011).
   PubMed Web of Science ®Google Scholar
• Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153(4), 1774–1782 (2012).
   Google Scholar
• Taguchi R, Yamada M, Nakajima Y et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 97(4), 1311–1319 (2012).
   PubMedGoogle Scholar
• Charmandari E, Sertedaki A, Kino T et al. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J. Clin. Endocrinol. Metab. 97(8), E1532–E1539 (2012).
   Google Scholar